Sensitivity of Spatiotemporal Gait Parameters in Measuring Disease Severity in Friedreich Ataxia

Cerebellum

Volumn 13, Issue 6, 2014, Pages 677-688

  Milne, Sarah C ^a,b,c,d   Hocking, Darren R ^e   Georgiou Karistianis, Nellie ^b   Murphy, Anna ^a,b   Delatycki, Martin B ^b,c,f   Corben, Louise A ^b,c,g  

^a Kingston Centre   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^d EASTERN HEALTH   (Australia)

^e LA TROBE UNIVERSITY   (Australia)

^f AUSTIN HEALTH   (Australia)

^g MONASH MEDICAL CENTRE   (Australia)

Author keywords

Cerebellum; Friedreich ataxia; Gait analysis; Neurodegenerative diseases; Outcome measure; Spatiotemporal

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY EQUILIBRIUM; CADENCE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DOUBLE SUPPORT PERCENTAGE OF THE CYCLE; FEMALE; FRIEDREICH ATAXIA; GAIT; GENE MUTATION; HEEL TO HEEL BASE OF SUPPORT; HUMAN; MALE; MUSCULOSKELETAL SYSTEM PARAMETERS; STRIDE LENGTH; SWING PERCENTAGE OF THE CYCLE; TRINUCLEOTIDE REPEAT; WALKING SPEED; BIOMECHANICS; GENETICS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; WALKING; YOUNG ADULT;

FRATAXIN; IRON BINDING PROTEIN; REPETITIVE DNA;

ADOLESCENT; ADULT; BIOMECHANICAL PHENOMENA; DNA REPEAT EXPANSION; FEMALE; FRIEDREICH ATAXIA; GAIT; HUMANS; IRON-BINDING PROTEINS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; WALKING; YOUNG ADULT;

EID: 84911372007     PISSN: 14734222     EISSN: 14734230     Source Type: Journal    
DOI: 10.1007/s12311-014-0583-2     Document Type: Article

References (59)

1. Cossée M, Schmitt M, Campuzano V, Reutenauer L, Moutou C, Mandel JL, et al. Evolution of the Friedreich’s ataxia trinucleotide repeat expansion: founder effect and premutations. Proc Natl Acad Sci U S A. 1997;94:7452–7.
2. Campuzano V, Montermini L, Moltò MD, Pianese L, Cossée M, Cavalcanti F, et al. Friedreich’s ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996;271:1423–7.
3. Delatycki MB, Williamson R, Forrest SM. Friedreich ataxia: an overview. J Med Genet. 2000;37:1–8.
4. Bidichandani SI, Delatycki MB. Friedreich ataxia. In GeneReviews. University of Washington. 1993. http://www.ncbi.nlm.nih.gov/books/NBK1281. Accessed 10 Sept 2013.
5. Pandolfo M. Friedreich ataxia: the clinical picture. J Neurol. 2009;256 Suppl 1:3–8.
6. Delatycki MB, Corben LA. Clinical features of Friedreich ataxia. J Child Neurol. 2012;27:1133–7.
7. Saute JA, Donis KC, Serrano-Munuera C, Genis D, Ramirez LT, Mazzetti P, et al. Ataxia rating scales–psychometric profiles, natural history and their application in clinical trials. Cerebellum. 2012;11:488–504.
8. White VB, Leib JR, Farmer JM, Biesecker BB. Exploration of transitional life events in individuals with Friedreich ataxia: implications for genetic counseling. Behav Brain Funct. 2010;6:65.
9. Delatycki MB. Evaluating the progression of Friedreich ataxia and its treatment. J Neurol. 2009;256 Suppl 1:36–41.
10. Fahey MC, Corben LA, Collins V, Churchyard AJ, Delatycki MB. The 25-foot walk velocity accurately measures real world ambulation in Friedreich ataxia. Neurology. 2007;68:705–6.
11. Givon U, Zeilig G, Achiron A. Gait analysis in multiple sclerosis: characterization of temporal-spatial parameters using GAITRite functional ambulation system. Gait Posture. 2009;29:138–42.
12. Friedman LS, Farmer JM, Perlman S, Wilmot G, Gomez CM, Bushara KO, et al. Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord. 2010;25:426–32.
13. Ebersbach G, Sojer M, Valldeoriola F, Wissel J, Müller J, Tolosa E, et al. Comparative analysis of gait in Parkinson’s disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy. Brain. 1999;122:1349–55.
14. Subramony SH, May W, Lynch D, Gomez C, Fischbeck K, Hallett M, et al. Measuring Friedreich ataxia: interrater reliability of a neurologic rating scale. Neurology. 2005;64:1261–2.
15. Marelli C, Figoni J, Charles P, Anheim M, Tchikviladze M, Vincitorio CM, et al. Annual change in Friedreich’s ataxia evaluated by the Scale for the Assessment and Rating of Ataxia (SARA) is independent of disease severity. Mov Disord. 2012;27:135–8.
16. Bürk K, Schulz SR, Schulz JB. Monitoring progression in Friedreich ataxia (FRDA): the use of clinical scales. J Neurochem. 2013;126 Suppl 1:118–24.
17. Peppe A, Chiavalon C, Pasqualetti P, Crovato D, Caltagirone C. Does gait analysis quantify motor rehabilitation efficacy in Parkinson’s disease patients? Gait Posture. 2007;26:452–62.
18. Rao AK, Quinn L, Marder KS. Reliability of spatiotemporal gait outcome measures in Huntington’s disease. Mov Disord. 2005;20:1033–7.
19. Serrao M, Pierelli F, Ranavolo A, Draicchio F, Conte C, Don R, et al. Gait pattern in inherited cerebellar ataxias. Cerebellum. 2012;11:194–211.
20. Gouelle A, Mégrot F, Presedo A, Husson I, Yelnik A, Penneçot GF. The Gait Variability Index: a new way to quantify fluctuation magnitude of spatiotemporal parameters during gait. Gait Posture. 2013;38:461–5.
21. Croarkin E, Maring J, Pfalzer L, Harris-Love M, Siegel K, DiProspero N. Characterizing gait, locomotor status, and disease severity in children and adolescents with Friedreich ataxia. J Neurol Phys Ther. 2009;33:144–9.
22. Schniepp R, Wuehr M, Schlick C, Huth S, Pradhan C, Dieterich M, et al. Increased gait variability is associated with the history of falls in patients with cerebellar ataxia. J Neurol. 2014;261:213–23.
23. Ilg W, Synofzik M, Brotz D, Burkard S, Giese MA, Schols L. Intensive coordinative training improves motor performance in degenerative cerebellar disease. Neurology. 2009;73:1823–30.
24. Fahey MC, Corben L, Collins V, Churchyard AJ, Delatycki MB. How is disease progress in Friedreich’s ataxia best measured? A study of four rating scales. J Neurol Neurosurg Psychiatry. 2007;78:411–3.
25. Kieseier BC, Pozzilli C. Assessing walking disability in multiple sclerosis. Mult Scler. 2012;18:914–24.
26. Webster KE, Wittwer JE, Feller JA. Validity of the GAITRite® walkway system for the measurement of averaged and individual step parameters of gait. Gait Posture. 2005;22:317–21.
27. Menz HB, Latt MD, Tiedemann A, Mun San Kwan M, Lord SR. Reliability of the GAITRite walkway system for the quantification of temporo-spatial parameters of gait in young and older people. Gait Posture. 2004;20:20–5.
28. Urbaniak GC, Plous S. Research randomizer 4.0 ed. 2013. http://www.randomizer.org. Accessed 01 Jun 2013.
29. Hollman JH, McDade EM, Petersen RC. Normative spatiotemporal gait parameters in older adults. Gait Posture. 2011;34:111–8.
30. Ilg W, Timmann D. Gait ataxia-specific cerebellar influences and their rehabilitation. Mov Disord. 2013;28:1566–75.
31. Bunn LM, Marsden JF, Giunti P, Day BL. Stance instability in spinocerebellar ataxia type 6. Mov Disord. 2013;28:510–6.
32. Patla AE. Strategies for dynamic stability during adaptive human locomotion. IEEE Eng Med Biol Mag. 2003;22:48–52.
33. Thach WT, Bastian AJ. Role of the cerebellum in the control and adaptation of gait in health and disease. Prog Brain Res. 2004;143:353–66.
34. Lythgo N, Wilson C, Galea M. Basic gait and symmetry measures for primary school-aged children and young adults whilst walking barefoot and with shoes. Gait Posture. 2009;30:502–6.
35. Vasudevan EVL, Torres-Oviedo G, Morton SM, Yang JF, Bastian AJ. Younger is not always better: development of locomotor adaptation from childhood to adulthood. J Neurosci. 2011;31:3055–65.
36. Akhlaghi H, Corben L, Georgiou-Karistianis N, Bradshaw J, Storey E, Delatycki MB, et al. Superior cerebellar peduncle atrophy in Friedreich’s ataxia correlates with disease symptoms. Cerebellum. 2011;10:81–7.
37. Rizzo G, Tonon C, Valentino ML, Manners D, Fortuna F, Gellera C, et al. Brain diffusion-weighted imaging in Friedreich’s ataxia. Mov Disord. 2011;26:705–12.
38. La Pean A, Jeffries N, Grow C, Ravina B, di Prospero NA. Predictors of progression in patients with Friedreich ataxia. Mov Disord. 2008;23:2026–32.
39. Morton SM, Bastian AJ. Relative contributions of balance and voluntary leg-coordination deficits to cerebellar gait ataxia. J Neurophysiol. 2003;89:1844–56.
40. Schniepp R, Wuehr M, Neuhaeusser M, Kamenova M, Dimitriadis K, Klopstock T, et al. Locomotion speed determines gait variability in cerebellar ataxia and vestibular failure. Mov Disord. 2012;27:125–31.
41. Callisaya ML, Blizzard L, Schmidt MD, McGinley JL, Srikanth VK. Ageing and gait variability-a population-based study of older people. Age Ageing. 2010;39:191–7.
42. Rochester L, Galna B, Lord S, Mhiripiri D, Eglon G, Chinnery PF. Gait impairment precedes clinical symptoms in spinocerebellar ataxia type 6. Mov Disord. 2014;29:252–5.
43. Ilg W, Golla H, Thier P, Giese MA. Specific influences of cerebellar dysfunctions on gait. Brain. 2007;130:786–98.
44. Swaine BR, Sullivan SJ. Reliability of the scores for the finger-to-nose test in adults with traumatic brain injury. Phys Ther. 1993;73:71–8.
45. Chen IH, Novak V, Manor B. Infarct hemisphere and noninfarcted brain volumes affect locomotor performance following stroke. Neurology. 2014;82:828–34.
46. Pandolfo M. Friedreich ataxia. Semin Pediatr Neurol. 2003;10:163–72.
47. Alper G, Narayanan V. Friedreich’s ataxia. Pediatr Neurol. 2003;28:335–41.
48. Sival DA, Pouwels ME, Van Brederode A, Maurits NM, Verschuuren-Bemelmans CC, Brunt ER, et al. In children with Friedreich ataxia, muscle and ataxia parameters are associated. Dev Med Child Neurol. 2011;53:529–34.
49. Horak FB. Postural ataxia related to somatosensory loss. Adv Neurol. 2001;87:173–82.
50. McCrea DA. Spinal circuitry of sensorimotor control of locomotion. J Physiol. 2001;533:41–50.
51. Lacquaniti F, Ivanenko YP, Zago M. Patterned control of human locomotion. J Physiol. 2012;590:2189–99.
52. Nardone A, Corna S, Turcato AM, Schieppati M. Afferent control of walking: are there distinct deficits associated to loss of fibres of different diameter? Clin Neurophysiol. 2014;125:327–35.
53. Stecina K, Fedirchuk B, Hultborn H. Information to cerebellum on spinal motor networks mediated by the dorsal spinocerebellar tract. J Physiol. 2013;591:5433–43.
54. Koeppen AH, Mazurkiewicz JE. Friedreich ataxia: neuropathology revised. J Neuropathol Exp Neurol. 2013;72:78–90.
55. Morral JA, Davis AN, Qian J, Gelman BB, Koeppen AH. Pathology and pathogenesis of sensory neuropathy in Friedreich’s ataxia. Acta Neuropathol (Berl). 2010;120:97–108.
56. He B, Lu Q, Wang Z. Coupling effect analysis between the central nervous system and the CPG network with proprioception. Robotica 2014 [In Press].
57. Borchers S, Synofzik M, Kiely E, Himmelbach M. Routine clinical testing underestimates proprioceptive deficits in Friedreich’s ataxia. Cerebellum. 2013;12:916–22.
58. Galna B, Lord S, Rochester L. Is gait variability reliable in older adults and Parkinson’s disease? Towards an optimal testing protocol. Gait Posture. 2013;37:580–5.
59. Paterson K, Hill K, Lythgo N. Stride dynamics, gait variability and prospective falls risk in active community dwelling older women. Gait Posture. 2011;33:251–5.